Global COVID-19 Caseload Tops 167.1 Million, Deaths Surge to More Than 3.46 Million: Johns Hopkins University

Washington, May 25: The overall global COVID-19 caseload has topped 167.1 million, while the deaths have surged to more than 3.46 million, according to the Johns Hopkins University. In its latest update on Tuesday morning, the University’s Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 167,112,793 and 3,469,530, respectively. Delaying Second Dose of COVID-19 vaccine in Under 65 May Cut Deaths: Study.

The US continues to be the worst-hit country with the world’s highest number of cases and deaths at 33,141,158 and 590,516, respectively, according to the CSSE. In terms of infections, India follows in the second place with 26,752,447 cases.

The other worst countries with over 3 million cases are Brazil (16,120,756), France (5,667,330), Turkey (5,194,010), Russia (4,952,412), the UK (4,480,760), Italy (4,194,672), Germany (3,659,990), Spain (3,647,520), Argentina (3,562,135) and Colombia (3,249,433), the CSSE figures showed.

In terms of deaths, Brazil comes second with 449,858 fatalities. Nations with a death toll of over 100,000 are India (303,720), Mexico (220,493), the UK (127,986), Italy (125,335), Russia (116,812) and France (108,819).

(The above story first appeared on Today News 24 on May 25, 2021 09:38 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website todaynews24.top).

//vdo (function(v,d,o,ai){ai=d.createElement('script');ai.defer=true;ai.async=true;ai.src=v.location.protocol+o;d.head.appendChild(ai);})(window, document, '//a.vdo.ai/core/latestly/vdo.ai.js');

//colombai try{ (function() { var cads = document.createElement("script"); cads.async = true; cads.type = "text/javascript"; cads.src = "https://static.clmbtech.com/ase/80185/3040/c1.js"; var node = document.getElementsByTagName("script")[0]; node.parentNode.insertBefore(cads, node); })(); }catch(e){}

} });

Comments (0)
Add Comment